↓ Skip to main content

Benzodiazepines for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs
1 blog
twitter
12 X users
weibo
1 weibo user
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
209 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benzodiazepines for schizophrenia
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd006391.pub2
Pubmed ID
Authors

Markus Dold, Chunbo Li, Magdolna Tardy, Vesal Khorsand, Donna Gillies, Stefan Leucht

Abstract

Because of the high number of people with schizophrenia not responding adequately to monotherapy with antipsychotic agents, the evidence regarding the efficacy and safety of additional medication was examined in a number of clinical trials. One approach to this research question was the use of benzodiazepines, as monotherapy as well as in combination with antipsychotics.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 209 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Unknown 207 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 14%
Student > Bachelor 27 13%
Researcher 19 9%
Student > Doctoral Student 14 7%
Student > Ph. D. Student 13 6%
Other 34 16%
Unknown 72 34%
Readers by discipline Count As %
Medicine and Dentistry 61 29%
Psychology 21 10%
Nursing and Health Professions 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Social Sciences 7 3%
Other 15 7%
Unknown 79 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2023.
All research outputs
#1,979,886
of 25,654,806 outputs
Outputs from Cochrane database of systematic reviews
#4,228
of 13,153 outputs
Outputs of similar age
#12,944
of 193,162 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 245 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,162 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 245 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.